FDA panel recommends controversial treatments
A controversial new FDA panel recommendation could affect the sale of peptides—popular treatments marketed for benefits ranging from muscle growth to weight loss.
NBC News’ Anne Thompson explains why not everyone thinks they’re a good idea. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
공식 발표 ↔ 진영별 보도
FDA panel recommends controversial treatments
FDA advisory panel recommends loosening restrictions on 2 unapproved peptides
FDA panel recommends easing restrictions on several peptides, including BPC-157
US health panel recommends easing restrictions on controversial peptides
+6
WATCH LIVE: Day 2 of FDA advisory panel meeting to consider use of peptides
An FDA Panel Just Endorsed These Unproven Peptides
FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists
FDA panel loosens restrictions for controversial peptides popular online
+8